Pilulka Lekarny AS (XPRA:PINK) ROE % Adjusted to Book Value: 0.00% (As of Dec. 2025)


XPRA:PINK Pilulka Lekarny AS XPRA:PINK
48 GF Score
Price Kč108.50
GF Value Kč113.58
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS ROE % Adjusted to Book Value?

Pilulka Lekarny AS XPRA:PINK -2.25% 48 ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 48/100 and a GF Value™ of Kč113.58 (Fairly Valued). The stock has 6 warning signs investors should review.

Pilulka Lekarny AS's ROE % for the quarter that ended in Dec. 2025 was 0.00%. Pilulka Lekarny AS's PB Ratio for the quarter that ended in Dec. 2025 was N/A. Pilulka Lekarny AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was N/A.

Pilulka Lekarny AS ROE % Adjusted to Book Value Related Terms

Pilulka Lekarny AS ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS ROE % Adjusted to Book Value Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -0.57 -3.22 -9.98 0.00 0.00

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pilulka Lekarny AS ROE % Adjusted to Book Value Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pilulka Lekarny AS ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's ROE % Adjusted to Book Value falls into.


XPRA:PINK
48GF Score
Pilulka Lekarny AS XPRA:PINK
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS ROE % Adjusted to Book Value Calculation

Pilulka Lekarny AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Pilulka Lekarny AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Pilulka Lekarny AS (XPRA:PINK) has a ROE % Adjusted to Book Value of 0.00% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's ROE % Adjusted to Book Value too high?
Pilulka Lekarny AS's current ROE % Adjusted to Book Value is 0.00%. Overall, Pilulka Lekarny AS has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's ROE % Adjusted to Book Value compare to competitors?
Pilulka Lekarny AS's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.58, compared to a current price of Kč108.50 — trading 4.5% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. Pilulka Lekarny AS's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current ROE % Adjusted to Book Value is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč108.50 is trading 4.5% below its estimated GF Value™ of Kč113.58. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • ROE % Adjusted to Book Value: 0.00%
  • GF Value™: Kč113.58 vs. price of Kč108.50 (4.5% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
48GF Score

Get the complete analysis for XPRA:PINK

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč108.50
Price
Kč113.58
GF Value